Evidence map›Paper›PMID 34804924›Full record

ArticleFrontiers in oncology2021

CNS Prophylaxis: How Far Is Routine Practice From the Guidelines? Focus on a Nationwide Survey by the Fondazione Italiana Linfomi (FIL).

Guido Gini, Alice Di Rocco, Luca Nassi, Annalisa Arcari, Maria Chiara Tisi, Giacomo Loseto, Attilio Olivieri, Massimo Gentile, Ombretta Annibali, Maria Giuseppina Cabras and 4 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Guido GiniClinic of Hematology, Ospedali Riuniti, Ancona, Italy.
Alice Di RoccoDepartment of Traslational and Precision Medicine, Sapienza University, Roma, Italy.
Luca NassiHematology, Department of Translational Medicine, University of Eastern Piedmont and AOU Maggiore della Carità, Novara, Italy.
Annalisa ArcariDivision of Hematology, Guglielmo da Saliceto Hospital, Piacenza, Italy.
Maria Chiara TisiDepartment of Hematology and Cell Therapy, San Bortolo Hospital, Vicenza, Italy.
Giacomo LosetoDivision of Hematology, IRCCS Ospedale Oncologico, Bari, Italy.
Attilio OlivieriClinic of Hematology, Ospedali Riuniti, Ancona, Italy.
Massimo GentileDepartment of Onco-Hematology, Hematology Unit, A.O of Cosenza, Cosenza, Italy.
Ombretta AnnibaliUnit of Hematology and Stem Cell Transplantation, University "Campus Bio-Medico", Rome, Italy.
Maria Giuseppina CabrasDivision of Hematology, Ospedale Oncologico Armando Businco, Cagliari, Italy.
Annalisa ChiappellaDepartment of Hematology, Azienda Ospedaliero Universitaria Citta`della Salute e della Scienza di Torino, Torino, Italy.
Chiara RusconiDivision of Hematology, Ospedale Niguarda Ca' Granda, Milan, Italy.
Andrés José María FerreriSan Raffaele Hospital, IRCCS, Milano, Italy.
Monica BalzarottiHematology Unit, IRCCS Humanitas Cancer Center, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

central nervous system involvementdiffuse large B cell lymphoma (DLBCL)prophylaxisrisk assessmentsurvey

Identifiers

PMID34804924
PMCPMC8602788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.